Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease: Grand Rounds Discussion...

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Practice Guidelines

Background:

• In November 2013, the American College of Cardiology and American Heart Association issued guidelines for managing blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk.
• The guidelines highlight four patient groups where statin therapy benefits for reducing ASCVD events outweigh potential adverse events.

Observation:

• A new pooled cohort equation-based risk estimator is introduced for calculating 10-year ASCVD risk.
• Clinician-patient discussion is recommended before initiating statin therapy, particularly for primary ASCVD prevention.

Findings:

• The guidelines identify specific patient populations who would benefit from statin therapy.
• A balanced approach is needed to initiate appropriate statin intensity, reduce ASCVD risk, and minimize adverse effects.

Implications:

• These recommendations aim to optimize ASCVD risk reduction strategies in adult patients.
• The paper explores practical application by summarizing a discussion between a cardiologist and internist on treatment decisions for an individual patient.